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Introduction. Endobronchial brachytherapy has indications for palliation or overprint affected if margins or small remains after
other treatments. The use of 2D or 3D images in treatment planning is useful to deﬁne the margins of irradiation volumes.
Alongside these images are applied directly or virtual bronchoscopy to secure the applicator or verify its position.
Purpose. To compare dosimetric parameters in treatment planning 2D, 3D and direct bronchoscopy. To evaluate the use of virtual
bronchoscope obtained from simulation images.
Method. Review of endobronchial application dosimetry. Obtaining the recommended dosimetric parameters. Retrospective
evaluation of virtual bronchoscopy as an aid to deﬁning volumes.
Results. In the studied dosimetry planning improves D90 3D vs. 2D planning. Planning bronchoscopy performed on direct, alone,
does not allow to delimit the depth of the lesion that it could not be compared. When direct bronchoscopy combined with virtual
results are closer to 3D planning.
Conclusions. 3D planning permits, in our institution, set the D90 to planned volume. By virtual bronchoscope is possible off-line
evaluation of implants.
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Introduction. Brachytherapy as only fraction boost after conservative surgery and radiotherapy in early stages of breast cancer is
a simple technique that reduces treatment time and produces little late toxicity.
Objectives. To describe our experience with adjuvant breast brachytherapy.
Materials and methods. We retrospectively analyzed 58 patients diagnosed with localized breast cancer, between January 2005 and
December 2012. They were treated with breast conservative surgery, EBRT and brachytherapy. We performed a descriptive study
of our patients.
Results. 58 patients mean age 58 (36–80). 87.9% with ductal inﬁltrating carcinoma. 45% located in CSE left breast. Distributed under
the current classiﬁcation of TNM, 55% stage I and 72% G1–2. 100% were treated with breast conserving surgery, mostly without
lymphovascular inﬁltration and 3.4% the resection margins are invaded by tumor, followed by EBRT and brachytherapy with
mean dose 7.11Gy (7–8.5) in only a fraction. The mean time between radiotherapy and brachytherapy was 15 days (3–30). The
mean follow-up 52.7 months (1–94). 93% had some degree of dermatitis, of these only 7% were G3. 15% patients had recurrence
(4% LR and DR, 11% DR, no LR only). 91% global survival, 90% live free of disease.
Conclusions. In this study, the disease relapse is lowbutwehave found a relation between tumor size, tumor grade and the distance
of the tumor resection margin, without founding relation with the time between EBRT and brachytherapy. Breast brachytherapy
as only fraction to surgery in patients with early stage tumor and small tumor offers good local control with good long-term
aesthetic results.
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